Decreased expression of cd44 in metastatic prostate cancer

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 478-483

  Noordzu, Marinus A ^a   Van Steenbrugge, Gert Jan ^a   Schröder, Fritz H ^a   Van Der Kwast, Theodorus H ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

AGED; ARTICLE; CANCER STAGING; CHEMISTRY; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR;

AGED; ANTIGENS, CD44; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 0033595633     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991022)84:5<478::aid-ijc5>3.0.co;2-n     Document Type: Article

References (19)

1. COMBARET, V ., LASSET, C ., FRAPPAZ, D ., BOUVIER, R ., THIESSE, P ., REBILLARD, A.-C ., PHILIP, T. and FAVROT, M.C ., Evaluation of CD44 prognostic value in neuroblastoma: comparison with other prognostic factors. Europ. J. Cancer ., 31A, 545-549 (1995).
2. DE MARZO, A.M ., BRADSHAW, C ., SAUVAGEOT, J ., EPSTEIN, J.I. and MILLER, G.J ., CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture. Prostate, 34, 162-168 (1998).
3. CAO, A.C ., Lou, W ., DOXG, J.T. and ISAACS, J.T ., CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 1 Ipl3. Cancer Res ., 57, 846-849 (1997).
4. GAO, A.C ., Lou, W ., SLEEMAN, J.P. and ISAACS, J.T ., Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate. Cancer Res ., 58, 2350-2352 (1998).
5. GÜNTHERT, U ., HOFMANN, M ., RUBY, W ., REBER, S ., ZÖLLER, M ., HAUSSMANN, L, MATZKU, S ., WENZEL, A ., PONTA, H. and HERRLICH, D ., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24(1991).
6. KALLAKURY, B.V ., SHEEHAN, C.E ., AMBROS, R.A ., FISHER, H.A ., KAUFMAN, R.P ., MURACA, P.J. and Ross, J.S ., Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas. J. din. Oncol ., 16, 1302-1309(1998).
7. KALLAKURY, B.V.S ., YANG, F ., FIGGE, J ., SMITH, K.E ., KAUSIK, S.J ., TACY, N.J ., FISHER, H.A.G ., KAUFMAN, R ., FIGGE, H. and Ross, J.S ., Decreased levels of CD44 protein and mRNA in prostate carcinoma: correlation with tumor grade and ploidy. Cancer, 78, 1461-1469 (1996).
8. KAUFMANN, M ., HEIDER, K.-H ., SLNN, H.-R, vox MINCKWTTZ, G ., PONTA, H. and HERRLICH, P ., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619 (1995).
9. MACKAY, C.R ., TERPE, H.-J ., STAUDER, R ., MARSTON, W.L ., STARK, H. and GüNTHERT, U ., Expression and modulation of CD44 variant isoforms in humans.y. CellBiol ., 124, 71-82(1994).
10. MULDER, J.W.R ., KRUYT, P.M ., SEWNATH, M ., OUSTING, J ., SELDENRUK, C.A ., WEIDEMA, W.F ., OFFERHAUS, G.J.A. and PALS, S.T ., Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, 1470-1472 (1994).
11. NAGABHUSHAN, M ., PRETLOW, T.G ., Guo, Y.J ., AMINI, S.B ., PRETLOW, T.P. and SY, M.S ., Altered expression of CD44 in human prostate cancer during progression. Amer. J. din. Pathol, 106, 647-651(1996).
12. NOORDZLJ, M.A ., VAN STEENBRUGGE, G.J ., VERKAIK, N.S ., SCHRÖDER, F.H. and VAN DER KWAST, T.H ., The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin. Cancer Res ., 3, 805-815(1997).
13. POTOSKY, A.L ., MILLER, B.A ., ALBERTSEV, P.C. and KRAMER, B.S ., The role of increasing detection in the rising incidence of prostate cancer. J, Amer. Med. Assoc ., 273, 548-552 (1995).
14. SCREATON, G.R ., BELL, M.V ., JACKSON, D.O ., CORNELIS, F.B ., GERTH, U. and BELL, J.I ., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sei. USA, 89, 12160-12164(1992).
15. SOBIN, L.H. and wmEKiND, C. (eds.), TNM classification of malignant tumours (5th ed.), Wiley-Liss, New York (1997).
16. STAUDER, R ., EISTERER, W ., THALER, J. and GüNTHERT, U ., CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood, 85, 2885-2899 (1995).
17. VAN DER GULDEN, J.W.J ., KIEMENEY, L.A.L.M ., VERBEEK, A.L.M. and STRAATMAN, H ., Mortality trends from prostate cancer in The Netherlands (1950-1989). Prostate, 24, 33-38 (1994).
18. VERKAIK, N.S ., TRAPMAN, J ., ROMIJN, J.C ., VAN DER K WAST, T.H. and VAN STEENBRUGGE, G.J ., Downregulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation. Int. J. Cancer, 80, 439-443 (1999).
19. ZHANG, M ., WANG, M.H ., SINGH, R.K ., WELLS, A. and SIEGAL, O.P ., Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts. J. biol. Chem ., 272, 14139-14146 (1997). Received 20 January 1999; Revised 26 May 1999